These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1328145)

  • 1. Cardiovascular actions of OPC-18790: a novel positive inotropic agent with little chronotropic action.
    Hosokawa T; Mori T; Fujiki H; Kinoshita S; Takemoto K; Imaizumi T; Noda T; Ohura M; Tominaga M; Yabuuchi Y
    Heart Vessels; 1992; 7(2):66-75. PubMed ID: 1328145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mode and mechanism of action of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, on the dog heart.
    Taira N; Endoh M; Iijima T; Satoh K; Yanagisawa T; Yamashita S; Maruyama M; Kawada M; Morita T; Wada Y
    Arzneimittelforschung; 1984; 34(3A):347-55. PubMed ID: 6331465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive inotropic and negative chronotropic effects of OPC-8490, a newly developed cardiotonic, in isolated, blood-perfused canine heart preparations.
    Furukawa Y; Akahane K; Haniuda M; Chiba S
    Jpn Heart J; 1989 May; 30(3):387-98. PubMed ID: 2552190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive inotropic and chronotropic effects of toborinone and its electrophysiological properties in the isolated hearts of rabbits and guinea-pigs.
    Takase H; Orito K; Mori T; Fujiki H; Sekiguchi K; Tominaga M; Iijima T
    Arzneimittelforschung; 1996 Jun; 46(6):579-86. PubMed ID: 8767347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac effects of the novel pyridazinone derivative 6-[4-[2-[3-(5-chloro-2-cyanophenoxy)-2-hydroxypropylamino]- 2- methylpropylamino]phenyl]-4,5-dihydro-5-methyl-3(2H) pyridazinone monoethyl maleate and its metabolite in isolated heart preparations of guinea pigs and dogs.
    Ishimori T; Gotanda K; Sasaki T; Shinbo A; Asano H; Miyazawa K; Miyasaka K
    Arzneimittelforschung; 1994 May; 44(5):583-8. PubMed ID: 7912931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo studies of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, in various animals.
    Yamashita S; Hosokawa T; Kojima M; Mori T; Yabuuchi Y
    Arzneimittelforschung; 1984; 34(3A):342-6. PubMed ID: 6331464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a novel cardiotonic agent (+-)-6-[3-(3,4-dimethoxybenzylamino)-2-hydroxypropoxy]-2(1H)-quinolino ne (OPC-18790) on contractile force, cyclic AMP level, and aequorin light transients in dog ventricular myocardium.
    Endoh M; Kawabata Y; Katano Y; Norota I
    J Cardiovasc Pharmacol; 1994 May; 23(5):723-30. PubMed ID: 7521454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
    Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M
    Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcellular mechanism of the positive inotropic effect of a new quinolinone derivative OPC-8490 on the dog ventricular myocardium.
    Endoh M; Satoh H; Norota I; Hirano K; Hosokawa T
    Heart Vessels; 1991; 6(3):158-67. PubMed ID: 1655692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inotropic mechanism of the phosphodiesterase inhibitor OPC 3911 alone and in combination with rolipram, studied in papillary muscles of ferret and guinea-pig and isolated myocytes of guinea-pig ventricular muscle.
    Mörner SE; Arlock P; Lindgren S
    Acta Physiol Scand; 1994 Mar; 150(3):325-34. PubMed ID: 8010139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of action of OPC-8490 in human ventricular myocardium.
    Focaccio A; Peeters G; Movsesian M; Roden R; Eki Y; Krall J; Bristow MR
    Circulation; 1996 Feb; 93(4):817-25. PubMed ID: 8641012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 1st communication: studies on isolated guinea pig cardiac muscles.
    Ogawa T; Ohhara H; Tsunoda H; Kuroki J; Shoji T
    Arzneimittelforschung; 1989 Jan; 39(1):33-7. PubMed ID: 2566308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiological effects of FK664, a new cardiotonic agent, on preparations from guinea pig ventricle and from rabbit sino-atrial node.
    Kodama I; Anno T; Sudo Y; Satake N; Shibata S
    Cardiovasc Res; 1989 May; 23(5):369-77. PubMed ID: 2558795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel positive inotropic agents: synthesis and biological activities of 6-(3-amino-2-hydroxypropoxy)-2(1H)-quinolinone derivatives.
    Fujioka T; Teramoto S; Mori T; Hosokawa T; Sumida T; Tominaga M; Yabuuchi Y
    J Med Chem; 1992 Oct; 35(20):3607-12. PubMed ID: 1331445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of MDL 17043 and MDL 19205, new positive inotropic agents, by use of isolated, blood-perfused dog-heart preparations.
    Wada Y; Taira N
    Heart Vessels; 1986; 2(1):29-35. PubMed ID: 2941407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dopamine on sinus rate and ventricular contractile force of the dog heart in vitro and in vivo.
    Endoh M
    Br J Pharmacol; 1975 Dec; 55(4):475-86. PubMed ID: 1212559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl] -2(1H)-quinolinone (OPC-8212), a new inotropic agent, on cardiotonic activity and coronary hemodynamics.
    Inoue M; Hori M; Nakajima S; Kitakaze M; Fukunami M; Ishida Y; Abe H
    Arzneimittelforschung; 1984; 34(3A):355-9. PubMed ID: 6540088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profile of cardiac and coronary vasodilator effects of MS-857, a novel cardiotonic agent, assessed in isolated, blood-perfused heart preparations of the dog.
    Maruyama M; Kamiya J; Kobari T
    J Cardiovasc Pharmacol; 1989 Nov; 14(5):777-82. PubMed ID: 2481193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OPC-18790, a novel positive inotropic agent, has both arterial and venous vascular dilating actions in the dog.
    Fujiki H; Mori T; Yoshida K; Imaizumi T; Tominaga M
    Eur J Pharmacol; 1996 Oct; 313(3):191-200. PubMed ID: 8911915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of toborinone (OPC-18790), a new positive inotropic agent, on action potential in guinea pig sinoatrial node: compared with milrinone and E-4031.
    Orito K; Takase H; Fujiki H; Mori T
    Jpn J Pharmacol; 1996 Sep; 72(1):79-82. PubMed ID: 8902604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.